This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Bakris, George
| Item Type | Name |
|
Concept
|
Receptors, Endothelin
|
|
Concept
|
Endothelin-1
|
|
Concept
|
Receptor, Endothelin A
|
|
Concept
|
Endothelins
|
|
Academic Article
|
The renin-angiotensin system in diabetic nephropathy: the endothelial connection.
|
|
Academic Article
|
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.
|
|
Academic Article
|
Arginine vasopressin stimulates human mesangial cell production of endothelin.
|
|
Academic Article
|
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
|
|
Academic Article
|
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial.
|
|
Academic Article
|
Endothelin antagonism in patients with resistant hypertension and hypertension nephropathy.
|
|
Academic Article
|
Renal adaptation to the failing heart. Understanding the cascade of responses.
|
|
Academic Article
|
Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells.
|
|
Academic Article
|
ACE inhibitor-mediated attenuation of mesangial cell growth. A role for endothelin.
|
|
Academic Article
|
Review: Insulin and endothelin: an interplay contributing to hypertension development?
|
|
Academic Article
|
Endothelin antagonism and hypertension: an evolving target.
|
|
Academic Article
|
Baseline characteristics and enrichment results from the SONAR trial.
|
|
Academic Article
|
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
|
|
Academic Article
|
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
|
|
Academic Article
|
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
|
|
Academic Article
|
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
|
|
Academic Article
|
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.
|
|
Academic Article
|
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease.
|
|
Academic Article
|
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
|
|
Concept
|
Endothelin A Receptor Antagonists
|
|
Concept
|
Endothelin Receptor Antagonists
|